Zegerid OTC is available without a prescription and is designed to relieve frequent heartburn. The medicine comes in capsule form and is taken once a day. As a proton pump inhibitor, Zegerid OTC works by decreasing acid production in the stomach. Although most people tolerate this medicine well, side effects are possible and may include headaches, diarrhea, and stomach pain.
Zegerid OTC is made by Schering-Plough HealthCare Products, Inc.
How Does Zegerid OTC Work?
Zegerid OTC belongs to a group of medications called proton pump inhibitors (PPIs). The stomach contains tiny pumps (called proton pumps) that produce acid. Zegerid OTC works by binding to the proton pumps and stopping them from producing acid. PPIs are very effective at decreasing acid production, as they work directly at the acid pumps.
PPI medications can be destroyed by stomach acid before they have a chance to be absorbed by the body. Other PPIs get around this problem by coating the medication with special delayed-release enteric coatings (which protect the medication until it reaches the small intestine).
Zegerid OTC is different; instead of a delayed-release coating, the capsules contain sodium bicarbonate (baking soda) that acts as a buffer. This allows the medication to dissolve immediately without being destroyed by stomach acid.
It is important to note that the medication does not provide immediate benefit, as all PPIs (including Zegerid OTC) can take a few days to start working.
Food and Drug Administration. FDA drug safety communication; low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs) (3/2/11). FDA Web site. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm245011.htm. Accessed March 17, 2011.
Clinical Pharmacology [database online]. Drug Interaction Report. Tampa, FL: Gold Standard, Inc.; 2010. Available at: http://www.clinicalpharmacology.com. Accessed March 17, 2011.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 5, 2010.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 5, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click